cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

Repositions product portfolio with effective, industry leading concentrations now supported by clinical claimsCharlotte, North Carolina--(Newsfile Corp. - December 15, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD, today announced our quarterly and full fiscal financial results for September 30, 2022. While we incurred a GAAP loss from operations of $78.

cbdMD Continues to Drive Operational Improvement

Charlotte, North Carolina--(Newsfile Corp. - December 14, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 15, 2022, to discuss the company's September 30, 2022 fourth quarter and fiscal 2022 financial results and business progress.CONFERENCE CALL DETAILSThursday, December 15, 2022, 4:15 p.m. Eastern Time

cbdMD, Inc. to Host Conference Call to Discuss Fourth Quarter and Fiscal 2022 Results

Charlotte, North Carolina--(Newsfile Corp. - November 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, has announced it has completed a successful initial launch into the emerging Japanese market. According to Brightfield Group, a leading CBD research firm, Japan is the largest CBD market by revenue in the Asia Pacific and Middle East region.

cbdMD Successfully Launches Into a Growing Japanese Market

Charlotte, North Carolina--(Newsfile Corp. - October 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announced today that the Company will present at the ThinkEquity Conference on Wednesday, October 26, 2022, at 12:30pm ET at the Mandarin Oriental Hotel in New York City.

cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York City

Formulated with Proprietary Cannabinoid Blend and Clinically Proven Ingredient to Address PainCharlotte, North Carolina--(Newsfile Corp. - October 18, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced their latest product launch geared toward the over 50 million Americans who suffer from some form of everyday pain or discomfort. cbdMD MAX features their innovative formula that combines cbdMD's proprietary cannabinoid blend with Univestin.

cbdMD Launches Powerful New Product Designed to Reduce Pain - cbdMD MAX

High Strength Product Designed to Make People Feel Their Best.Charlotte, North Carolina--(Newsfile Corp. - October 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced their latest initiative that involves a new line up of products delivering higher concentrations of CBD for daily use. According to category insights, people need to take enough CBD so they can feel better and at a price they can afford every day.

cbdMD Announces Strategic Launch of Strongest CBD at the Best Value

Launch Includes 5 cbdMD SKUs with the retailer across the US East CoastCharlotte, North Carolina--(Newsfile Corp. - September 28, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced an agreement with regional grocery retailer, Wegmans Food Market, Inc. The initial launch will feature 5 SKUs from cbdMD, making Wegmans the first major grocer to include ingestible cbdMD products as a part of their in-store selection.

cbdMD Launches Line of CBD Products with Wegmans Food Markets

cbdMD, Inc. (NYSE:YCBD ) Q3 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Scott Stephen - Chairman Kevin MacDermott - President Dr. Sibyl Swift - Vice President of Scientific and Regulatory Affairs Conference Call Participants Jeff Porter - Porter Capital Management Operator Good afternoon. Welcome to the cbdMD Inc.'s June 30, 2022 Third Quarter of Fiscal 2022 Earnings Call and Update.

cbdMD, Inc. (YCBD) Q3 2022 Results - Earnings Call Transcript

Management delivers on operating improvements while investing in future growth. cbdMD board appoints Dr. Sibyl Swift to the Board of Directors to fill Vacancy.Charlotte, North Carolina--(Newsfile Corp. - August 11, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, today announced our financial results for June 30, 2022.

cbdMD Delivers on its Promise of Operating Improvement, adds Regulatory Depth to the Board

Charlotte, North Carolina--(Newsfile Corp. - August 8, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the world's leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday, August 11, 2022, to discuss the company's June 30, 2022 third quarter financial results and business progress.CONFERENCE CALL DETAILSThursday, August 11, 2022, 4:30 p.m. Eastern TimeU

cbdMD, Inc. to Host Conference Call to Discuss June 30, 2022, Third Quarter Results

Charlotte, North Carolina--(Newsfile Corp. - June 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, presented testimony at the public advisory committee meeting of the Science Board to the Food and Drug Administration (FDA) held earlier in June. The Company's V.P. of Science and Regulatory Affairs, Dr. Sibyl Swift, was invited to present testimony related to the safety...

cbdMD's Dr. Sibyl Swift Provides Testimony To the FDA Science Board on Proper Safety Methods for CBD Products

Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), announced today that Martin Sumichrast has resigned as CEO and member of the Board of Directors, effective immediately. Board member Scott Stephen was named Board Chair and board member Scott Coffman, former co-CEO and the operating company founder, will consult with the Board of Directors in leading the company until a new CEO is named."We appreciate the years...

cbdMD, Inc. CEO Steps Down

Charlotte, North Carolina--(Newsfile Corp. - June 1, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies and operator of three of the leading CBD brands - its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals - will be in attendance at the 2022 Mid-Atlantic Legislative Conference in White Sulphur Springs, West...

cbdMD Leadership to Attend Mid-Atlantic Legislative Conference on June 1 in WV

Charlotte, North Carolina--(Newsfile Corp. - June 1, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), announced today that the company has learned that the Securities and Exchange Commission ("SEC") has brought a civil action against Martin Sumichrast, relating to a private company previously managed by Mr. Sumichrast, which was dissolved in early 2020. The company notes that the complaint does not allege any wrongdoing by cbdMD, Inc. However, the complaint states that Mr....

cbdMD, Inc. Addresses Executive SEC Matter

Charlotte, North Carolina--(Newsfile Corp. - May 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- announced today that Martin Sumichrast, its Chairman & Chief Executive Officer, and members of the cbdMD...

cbdMD To Attend Jefferies Cannabis Summit On June 2nd In NYC

cbdMD, Inc. (NYSE:YCBD ) Q2 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Ronan Kennedy - CFO and COO Marty Sumichrast - Chairman and Co-CEO Sibyl Swift - VP, Scientific & Regulatory Affairs Conference Call Participants Operator Good afternoon, and welcome to cbdMD, Inc.'s March 31, 2022, Second Quarter of Fiscal 2022 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its second quarter of fiscal year 2022 results, which followed the filing of its quarterly report on Form 10-Q.

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q2 2022 Results - Earnings Call Transcript

Charlotte, North Carolina--(Newsfile Corp. - May 16, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- announced today that effective immediately, Scott Coffman, has retired from his position as President and co-CEO...

cbdMD Announces Management Changes

Positive Near-Term Sales Trend Expected, Significant Operational Adjustments ImplementedCharlotte, North Carolina--(Newsfile Corp. - May 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- today announced our financial results for March 31, 2022, as we generated $9.6 million in net...

cbdMD Reports Sequential Increase in Net Sales

This release corrects and replaces the previous release editing the date of the Quarter Ending March 30 to March 31, 2022.Charlotte, North Carolina--(Newsfile Corp. - May 6, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the world's leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:30 p.m., Eastern Time, on Friday, May 13, 2022, to discuss the...

CORRECTION FROM SOURCE: cbdMD, Inc. to Host Conference Call to Discuss March 31, 2022, Second Quarter Results

Charlotte, North Carolina--(Newsfile Corp. - May 6, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the world's leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:30 p.m., Eastern Time, on Friday, May 13, 2022, to discuss the company's March 30, 2022, second quarter financial results and business progress.CONFERENCE CALL DETAILSFriday, May 13, 2022, 4:30 p.m. Eastern TimeUSA/Canada:

cbdMD, Inc. to Host Conference Call to Discuss March 30, 2022, Second Quarter Results

AFC Gamma

Agrify

Akanda Corp

Aircastle Ltd.

Clever Leaves Holdings Inc

High Tide

Neptune Wellness Solutions Inc.

The Valens Co

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

It's 420 Holiday Week! These 9 Cannabis Stocks Are on Fire

Together With The Recent UK Validation, Total Addressable Population Exceeds 500 MillionCharlotte, North Carolina--(Newsfile Corp. - April 19, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), (the "Company") announced today that it has received validation of its Novel Food Application from the European Union's Food Safety Authority ("FSA") for its hemp extract formulation. This validation represents a significant milestone and provides the Company an opportunity to expand its global footprint in an anticipated growing marketplace, that together with the UK, has a total addressable...

EU's Food Safety Authority Validates cbdMD's Hemp Extract Formulation

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) one of the world's leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840 retail GNC Holdings, LLC (GNC) stores nationwide. cbdMD first partnered with GNC in August 2020, and included a roll-out of three topical SKUs at under 100 retail stores nationwide. Due to consumer receptivity and overall purchasing

cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNC

Arena Pharmaceuticals

Flora Growth Corp

HEXO Corp

FSD Pharma

Innovative Industrial Properties

Tilray Brands

22nd Century Group

WM Technology

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

11 Marijuana Stocks on Fire to Close February

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the world's leading and most highly trusted and recognized health & wellness CBD companies, today announced that the Natural Products Association (NPA) filed a Citizen's Petition on cbdMD's behalf with the Food and Drug Administration (FDA) requesting the FDA to remove the drug exclusion for CBD and to review the Company's extensive dossier of identity, safety and quality data. Removing the d

News for cbdMD Inc Stock (YCBD)